Defunct Company
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
80
NCT00087789
CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
Phase: Phase 1
Role: Collaborator
Start: Jun 30, 2004
Completion: May 31, 2010
NCT00252850
Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
Start: Jun 30, 2005
Completion: Mar 31, 2007
NCT00400634
Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease
Phase: Phase 2
Start: Nov 30, 2006
Completion: Nov 30, 2008